Delek US Holdings, Inc. 10-Q

ITEM 5. OTHER INFORMATION Rule 10b5-1 Trading Plans During the quarter ended September 30, 2025, none of our directors or officers (as defined in Rule 16a-1 under the Exchange Act) adopted , modified or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 105b-1 trading arrangement" (as those terms are defined in Item 408 of Regulation S-K), except as follows: On August 13, 2025 , Reuven Spiegel , Executive Vice President, Special Projects , amended a Rule 10b5-1 trading arrangement originally entered into on March 6, 2025. The amended Rule 10b5-1 trading arrangement is for the sale of up to 10,000 shares of our common stock, subject to certain conditions. The arrangement's expiration date is March 31, 2026 . On September 10, 2025 , Robert Wright , Senior Vice President & Deputy Chief Financial Officer , entered into a Rule 10b5-1 trading arrangement for the sale of 61,325 shares of our common stock, subject to certain conditions. This arrangement's expiration date is April 15, 2027 . 75 | Exhibits ITEM 6. EXHIBITS Exhibit No. Description 10.1 # F orm of Indemnification Agreement for Directors and Officers of Delek US Holdings, Inc. 31.1 # Certification of the Company’s Chief Executive Officer pursuant to Rule 13a-14(a)/15(d)-14(a) under the Securities Exchange Act of 1934, as amended. 31.2 # Certification of the Company’s Chief Financial Officer pursuant to Rule 13a-14(a)/15(d)-14(a) under the Securities Exchange Act of 1934, as amended. 32.1 ## Certification of the Company’s Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 32.2 ## Certification of the Company’s Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 101 The following materials from Delek US Holdings, Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of September 30, 2025 and September 30, 2024 (Unaudited), (ii) Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2025 and 2024 (Unaudited), (iii) Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2025 and 2024 (Unaudited), (iv) Condensed Consolidated Statements of Changes in Stockholders' Equity for the three and nine months ended September 30, 2025 and 2024 (Unaudited), (v) Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 2024 (Unaudited), and (vi) Notes to Condensed Consolidated Financial Statements (Unaudited). 104 The cover page from Delek US Holdings, Inc.'s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, has been formatted in Inline XBRL. * Management contract or compensatory plan or arrangement # Filed herewith ## Furnished herewith 76 | SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Delek US Holdings, Inc. By: /s/ Avigal Soreq Avigal Soreq President and Chief Executive Officer (Principal Executive Officer) By: /s/ Mark Hobbs Mark Hobbs Executive Vice President, Chief Financial Officer (Principal Financial Officer) By: /s/ Robert Wright Robert Wright Senior Vice President and Deputy Chief Financial Officer (Principal Accounting Officer) Dated: November 7, 2025 77 |